8109.0 - Research and Experimental Development, Government and Private Non-Profit Organisations, Australia, 2018-19 Quality Declaration 
Latest ISSUE Released at 11:30 AM (CANBERRA TIME) 19/06/2020   
   Page tools: Print Print Page Print all pages in this productPrint All RSS Feed RSS Bookmark and Share Search this Product

Private Non-Profit Resources Devoted to Research and Experimental Development (R&D)

  • Expenditure on R&D performed by Australian private non-profit (PNP) organisations during the 2018-19 financial year was $1,269 million.
  • Private non-profit expenditure on R&D (PNPERD) increased by 22% in current price terms and 20% in chain volume terms between 2016-17 and 2018-19.
  • PNPERD as a proportion of GDP increased from 0.06% in 2016-17 to 0.07% in 2018-19.


Private non-profit Resources Devoted to R&D

2008-09
2011-12
2012-13
2014-15
2016-17
2018-19

Expenditure on R&D
Current prices $m
744
944
961
1 007
1 040
1 269
Chain volume measures(a) $m
881
1 027
1 017
1 049
1 058
1 269
Human resources devoted to R&D PYE
4 788
5 256
5 678
6 019
6 178
7 205

(a) The reference year for chain volume measures is 2018-19. See Explanatory Notes for details.


Expenditure figures and supporting commentary below are presented in current price values.


Private non-profit expenditure on R&D (PNPERD)


Type of expenditure

  • PNPERD included $1,205 million (95%) in Current expenditure and $64 million (5%) in Capital expenditure. Compared with 2016-17, Current expenditure increased $216 million (22%) and Capital expenditure increased $13 million (26%).
  • The largest component of PNPERD was Labour costs, at $691 million (54%), followed by Other current expenditure, which includes all other non-staff expenditure, at $514 million (41%). Labour costs recorded the largest increase in PNPERD, up $119 million (21%) from 2016-17.


Source of funds
  • The two main sources of funds for PNPERD were Commonwealth government funds ($432 million or 34% of PNPERD) and Own funds ($283 million or 22% of PNPERD).
  • Commonwealth government funding recorded the largest dollar increase between 2016-17 and 2018-19, up $47 million (12%). This was followed by Donations and bequests, up $44 million (99%).


Location

Location of expenditure relates to the region in which R&D activity was performed. Please refer to the Location of R&D section of the Explanatory Notes for further information.
  • Victoria ($574 million) and New South Wales ($441 million) accounted for 80% of PNPERD.
  • Between 2016-17 and 2018-19, New South Wales recorded the largest increase in dollar terms up $110 million (33%), followed by Victoria up $58 million (11%).


PNPERD, Top 5 Locations
Graph shows 2018-19 PNPERD expenditure by location in the following order: 1 Victoria; 2 New South Wales; 3 Western Australia; 4 Queensland; 5 Overseas.



PNPERD and Gross State Product (GSP)


PNPERD, by location of expenditure - proportion of GSP(a)

NSW
Vic.
Qld
SA
WA
Tas.
NT
ACT
%
%
%
%
%
%
%
%

2016-17
0.06
0.13
0.02
0.02
0.03
-
0.02
0.02
2018-19
0.07
0.13
0.02
np
0.03
0.01
np
0.01

- nil or rounded to zero (including null cells).
np not available for publication but included in totals where applicable, unless otherwise indicated.
(a) Refer to the Gross Domestic Product (GDP) and Gross State Product (GSP) section of the Explanatory Notes for details.


Type of activity
  • The largest component of Type of activity was Applied research totalling $488 million (38% of PNPERD), followed by Strategic basic research, at $466 million (37%), Experimental development at $271 million (21%) and Pure basic research at $45 million (4%).
  • Between 2016-17 and 2018-19, Applied research recorded the largest increase in dollar terms, up $118 million (32%).


Fields of Research (FOR)
  • Medical and Health Sciences, at $1,074 million remained the largest Field of Research accounting for three quarters (85%) of total PNPERD.
  • Medical and Health Sciences recorded the largest dollar increase of $177 million (20%) between 2016-17 and 2018-19.


Socio-economic Objective (SEO)
  • The majority of PNPERD (88%) was directed to the Socio-economic Objective of Health ($1,118 million) in 2018-19, followed by Education and Training ($39 million or 3%).
  • Between 2016-17 and 2018-19, Health recorded the largest dollar increase, up $186 million (20%).


Private non-profit human resources devoted to R&D
  • Australian non-profit organisations devoted a total of 7,205 person years of effort (PYE) to R&D in 2018-19, an increase of 1,027 PYE (17%) since 2016-17.
  • Researchers accounted for the majority of human resources effort devoted to R&D in 2018-19, totalling 4,703 PYE (65%), followed by Technicians (1,269 PYE or 18%) and Other staff (1,233 or 17%).


New ABS Website

The ABS will be launching a new website in 2020. You will soon be able to see how this release will appear on the new website by exploring our Beta site. Regular users of this information are encouraged to explore the Beta site and consider if this will affect the way you access and consume ABS data and information. If you would like more information on the new ABS website, or want to discuss how the transition to the new site might impact you, please email newABSwebsite@abs.gov.au.